The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...

The antisense oligonucleotide was even more effective in patients with relatively low viral activity. More than one-quarter of these individuals had undetectable levels of the virus in the blood for ...

Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...

Drug candidate bepirovirsen delivered a functional cure rate for 19% of patients in what the company sees as a breakthrough ...

A new drug has cured 20% of patients with a chronic, cancer-causing disease — which was previously incurable. A viral ...

An Ionis Pharmaceuticals drug has preliminary data showing it met the main goal of its pivotal test in a rare disease with only a handful of approved treatments. With these results in hand, Ionis is ...

Ionis Pharmaceuticals, a California company that pioneered a whole class of RNA-targeted medicines, reported on Friday that a pair of late-stage trials showed that its experimental therapy for ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Ionis Pharmaceuticals won approval from the Food and Drug Administration on ...

Ionis Pharmaceuticals IONS signed a license agreement with Japan-based Ono Pharmaceutical. Per the terms, Ono has acquired exclusive global rights from IONS to develop and market sapablursen, an ...